Home / Latest Science News -- ScienceDaily / Genetic study of liver cancer reveals new drug target

Genetic study of liver cancer reveals new drug target

Drugs targeting the gene MAGEA3 may help block the growth of hepatocellular carcinoma (HCC), the most common type of primary liver cancer and one of the leading causes of cancer deaths in the country. That's one conclusion of a new study analyzing the genetics of HCC tumors.

from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/06/210624141533.htm
Genetic study of liver cancer reveals new drug target Genetic study of liver cancer reveals new drug target Reviewed by cmakigo on June 25, 2021 Rating: 5

You May Also Like

No comments:

Post a Comment

Subscribe to: Post Comments ( Atom )
'; (function() { var dsq = document.createElement('script'); dsq.type = 'text/javascript'; dsq.async = true; dsq.src = '//' + disqus_shortname + '.disqus.com/embed.js'; (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(dsq); })();
Powered by Blogger.